propranolol and semaglutide Propranolol: Drug Interactions Guide Oral Semaglutide for Weight Loss

Trial-Reported Endpoints by Phase Trial Lancet 2021 Phase 2 Duration 26 weeks Population Overweight/obese, no T2D (n=706) Mean Weight Loss 10.8% at 4.5 mg vs 3.0% placebo Trial Lancet 2023 Phase 2 Duration 32 weeks Population T2D + obesity (n=92) Mean Weight Loss 8.1% cagrilintide alone

excess ingredients that fail to absorb are discharged along with urine

Instead, the improvement in HbA1c correlated with CPR and CPI, suggesting that the level of residual beta-cell function is associated with the efficacy of oral semaglutide treatment, which has been shown for other GLP-1RAs (Supplementary Table 4) [30,31,32]

The medication is still suppressing appetite, but the gap between intake and expenditure has narrowed enough to stall progress